Хайлтын үр дүнгүүд - Stephanie Bruns
- 2-н 1 - 2 үр дүнгүүдийг харуулж байна
-
1
Short-term safety of mTOR inhibitors in infants and very young children with tuberous sclerosis complex (TSC): Multicentre clinical experience -н Darcy A. Krueger, Jamie K. Capal, Paolo Curatolo, Orrin Devinsky, Kevin C. Ess, Michal Tzadok, Mary Kay Koenig, Vinodh Narayanan, Federico Ramos, Sergiusz Jóźwiak, Petrus de Vries, Anna Jansen, Michael Wong, David Mowat, John A. Lawson, Stephanie Bruns, David Neal Franz
Хэвлэсэн 2018Artigo -
2
Multicenter Cohort Study of Infliximab Pharmacokinetics and Therapy Response in Pediatric Acute Severe Ulcerative Colitis -н Kaitlin G. Whaley, Ye Xiong, Rebekah Karns, Jeffrey S. Hyams, Subra Kugathasan, Brendan M. Boyle, Thomas D. Walters, Judith R. Kelsen, Neal S. LeLeiko, Jason M. Shapiro, Amanda Waddell, Sejal R. Fox, Ramona Bezold, Stephanie Bruns, Robin Widing, Yael Haberman, Margaret H. Collins, Tomoyuki Mizuno, Phillip Minar, Geert D’Haens, Lee A. Denson, Alexander A. Vinks, Michael J. Rosen
Хэвлэсэн 2022Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Dosing
Internal medicine
Medicine
Adverse effect
Apoptosis
Biochemistry
Chemistry
Cohort
Colectomy
Confidence interval
Discovery and development of mTOR inhibitors
Disease
Everolimus
Gastroenterology
Hazard ratio
Infliximab
PI3K/AKT/mTOR pathway
Pathology
Pediatrics
Pharmacokinetics
Prospective cohort study
Sirolimus
Tuberous sclerosis
Ulcerative colitis